Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Diemberger

Showing results (51-60 of 238) with videos related to

Pageof 24
Sort By:
Vaccines|January 7, 2021
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBaseMilo Gatti, Emanuel Raschi, Ugo Moretti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 19, 2014
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy?Giuseppe Boriani, Matteo Ziacchi, Igor Diemberger, et al.
European Heart Journal|July 4, 2008
How to assess the efficacy of catheter ablation of atrial fibrillation?Cristian Martignani, Igor Diemberger, Mauro Biffi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 5, 2014
Cardiac resynchronization therapy: the conundrum of predicting response in the individual patientGiuseppe Boriani, Matteo Ziacchi, Igor Diemberger, et al.
European Journal of Preventive Cardiology|August 17, 2021
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting systemMilo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, et al.
Expert Opinion on Pharmacotherapy|November 3, 2020
SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?Emanuel Raschi, Gian Paolo Fadini, Igor Diemberger, et al.
International Journal of Cardiology|December 9, 2008
Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interactionGiuseppe Boriani, Mauro Biffi, Igor Diemberger, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2024
Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulantsMassimo Carollo, Salvatore Crisafulli, Francesco Ciccimarra, et al.
International Journal of Cardiology|September 22, 2018
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemRiccardo Mei, Emanuel Raschi, Emanuele Forcesi, et al.
Immunobiology|November 20, 2019
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemiaCristian Martignani, Giulia Massaro, Antonio Giulio Bruno, et al.
Pageof 24

Showing results (51-60 of 238) with videos related to

Sort By:
Pageof 24
Vaccines|January 7, 2021
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBaseMilo Gatti, Emanuel Raschi, Ugo Moretti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 19, 2014
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy?Giuseppe Boriani, Matteo Ziacchi, Igor Diemberger, et al.
European Heart Journal|July 4, 2008
How to assess the efficacy of catheter ablation of atrial fibrillation?Cristian Martignani, Igor Diemberger, Mauro Biffi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 5, 2014
Cardiac resynchronization therapy: the conundrum of predicting response in the individual patientGiuseppe Boriani, Matteo Ziacchi, Igor Diemberger, et al.
European Journal of Preventive Cardiology|August 17, 2021
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting systemMilo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, et al.
Expert Opinion on Pharmacotherapy|November 3, 2020
SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?Emanuel Raschi, Gian Paolo Fadini, Igor Diemberger, et al.
International Journal of Cardiology|December 9, 2008
Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interactionGiuseppe Boriani, Mauro Biffi, Igor Diemberger, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2024
Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulantsMassimo Carollo, Salvatore Crisafulli, Francesco Ciccimarra, et al.
International Journal of Cardiology|September 22, 2018
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemRiccardo Mei, Emanuel Raschi, Emanuele Forcesi, et al.
Immunobiology|November 20, 2019
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemiaCristian Martignani, Giulia Massaro, Antonio Giulio Bruno, et al.
Pageof 24